Skip to main content
OpenTrials

Clinical trial condition

Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8

Explore clinical trials studying Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 trial results

Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions